Impact of early central venous catheter removal on outcome in patients with candidaemia

被引:60
作者
Rodriguez, D.
Park, B. J.
Almirante, B.
Cuenca-Estrella, M.
Planes, A. M.
Mensa, J.
Gimenez, M.
Saballs, P.
Fridkin, S. K.
Rodriguez-Tudela, J. L.
Pahissa, A.
机构
[1] Univ Autonoma Barcelona, Infect Dis Div, Hosp Univ Vall Hebron, Dept Med, Barcelona 08035, Spain
[2] Natl Ctr Zoonot, Mycot Dis Branch, Div Foodborne Bacterial & Mycot Dis, Atlanta, GA USA
[3] Ctr Dis Control & Prevent, Enter Dis Coordinating Ctr Infect Dis, Atlanta, GA USA
[4] Inst Salud Carlos III, Dept Mycol, Madrid, Spain
[5] Univ Autonoma Barcelona, Dept Microbiol, Hosp Univ Vall Hebron, Barcelona 08035, Spain
[6] Hosp Clin IDIBAPS, Div Infect Dis, Barcelona, Spain
[7] Hosp Germans Trias & Pujol, Dept Microbiol, Barcelona, Spain
[8] Hosp del Mar, Div Infect Dis, Barcelona, Spain
关键词
candidaemia; central venous catheter; early removal; mortality; outcome; risk-factors;
D O I
10.1111/j.1469-0691.2007.01758.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Removal of central venous catheters (CVCs) from candidaemic patients is considered the reference standard of care, although this practice is not always possible. The impact of prompt catheter removal on outcome was investigated by analysing data from an active population-based surveillance study in Barcelona, Spain. Patients with candidaemia and a CVC were identified between January 2002 and December 2003. Cases with CVC removal within 2 days were classified as having early CVC removal. Outcome, defined as in-hospital mortality 2-30 days after diagnosis of candidaemia, was determined among hospitalised adults using univariate, Kaplan-Meier and multivariate logistic regression analysis. Outpatients, paediatric patients and those who died or were discharged within 2 days were excluded. The study identified 265 patients with candidaemia and a CVC. Median time from diagnosis of candidaemia to catheter removal was 1 day (range 0-29 days). Overall, 172 patients met the criteria for inclusion in the outcome study. Patients with early CVC removal differed significantly from those with delayed CVC removal. According to univariate, Kaplan-Meier and multivariate analysis, the marker most predictive of in-hospital mortality among candidaemic patients with CVCs was severity of illness. These data suggest that timing of CVC removal may best be determined after carefully considering the risks and benefits to individual patients.
引用
收藏
页码:788 / 793
页数:6
相关论文
共 22 条
  • [1] Epidemiology and predictors of mortality in cases of Candida bloodstream infection:: Results from population-based surveillance, Barcelona, Spain, from 2002 to 2003
    Almirante, B
    Rodríguez, D
    Park, BJ
    Cuenca-Estrella, M
    Planes, AM
    Almela, M
    Mensa, J
    Sanchez, F
    Ayats, J
    Gimenez, M
    Saballs, P
    Fridkin, SK
    Morgan, J
    Rodriguez-Tudela, JL
    Warnock, DW
    Pahissa, A
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (04) : 1829 - 1835
  • [2] Predictors of adverse outcome in cancer patients with candidemia
    Anaissie, EJ
    Rex, JH
    Uzun, Ö
    Vartivarian, S
    [J]. AMERICAN JOURNAL OF MEDICINE, 1998, 104 (03) : 238 - 245
  • [3] BECKSAGUE CM, 1993, J INFECT DIS, V167, P1247, DOI 10.1093/infdis/167.5.1247
  • [4] CANDIDEMIA IN CHILDREN WITH CENTRAL VENOUS CATHETERS - ROLE OF CATHETER REMOVAL AND AMPHOTERICIN-B THERAPY
    DATO, VM
    DAJANI, AS
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1990, 9 (05) : 309 - 314
  • [5] EPPES SC, 1989, PEDIATR INFECT DIS J, V8, P99
  • [6] Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: Clinical aspects, predisposing factors, and differential pathogenicity of the causative strains
    Girmenia, C
    Martino, P
    DeBernardis, F
    Gentile, G
    Boccanera, M
    Monaco, M
    Antonucci, G
    Cassone, A
    [J]. CLINICAL INFECTIOUS DISEASES, 1996, 23 (03) : 506 - 514
  • [7] CLINICAL-FEATURES AND ANALYSIS OF RISK-FACTORS FOR INVASIVE CANDIDAL INFECTION AFTER MARROW TRANSPLANTATION
    GOODRICH, JM
    REED, EC
    MORI, M
    FISHER, LD
    SKERRETT, S
    DANDLIKER, PS
    KLIS, B
    COUNTS, GW
    MEYERS, JD
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (04) : 731 - 740
  • [8] Hung CC, 1996, J FORMOS MED ASSOC, V95, P19
  • [9] KARKOWICZ MG, 2000, PEDIATRICS, V106, pE63
  • [10] VASCULAR CATHETER ASSOCIATED FUNGEMIA IN PATIENTS WITH CANCER - ANALYSIS OF 155 EPISODES
    LECCIONES, JA
    LEE, JW
    NAVARRO, EE
    WITEBSKY, FG
    MARSHALL, D
    STEINBERG, SM
    PIZZO, PA
    WALSH, TJ
    [J]. CLINICAL INFECTIOUS DISEASES, 1992, 14 (04) : 875 - 883